Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Beta Drugs Ltd.
NSE: BETA
|
BSE: 531481
|
ISIN: INE351Y01019
|
Industry: Pharmaceuticals
|
Expensive Performer
2054.3000
-50.90
(
-2.42
%)
NSE
Sep 16, 2026
11:11 AM
26.84% Fall from 52W High
Volume:
8,764
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Beta Drugs Ltd.
08 Nov 2024
2054.30
-2.42%
Beta Drugs | H1FY25 Result Update
Buy:
Beta Drugs Ltd.
by
Edelweiss
Target: 2245
Target
Edelweiss
Strong show in H1; near-term growth factored in
Beta Drugs has lost
-19.46%
in the last 1 Month
More from Beta Drugs Ltd.
Recommended
Market trades higher, Blue Dart Express MD Balfour Manuel seeks early retirement
Trendlyne Marketwatch |
16 Sep 2026, 11:10AM
Primary market gears up for NSE’s long-awaited IPO
|
15 Sep 2026, 06:52PM
Five Interesting Stocks Today - September 11, 2026
The Baseline |
11 Sep 2026